Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy

JU HYE OK, HOSUN LEE, HAE-YUN CHUNG, SUNG HWAN LEE, EUN JEONG CHOI, CHANG MOO KANG and SONG MI LEE
Anticancer Research November 2018, 38 (11) 6519-6527; DOI: https://doi.org/10.21873/anticanres.13017
JU HYE OK
1Department of Nutrition Care, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HOSUN LEE
1Department of Nutrition Care, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HAE-YUN CHUNG
2Department of Food and Nutrition, Soongeui Women's University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUNG HWAN LEE
3Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea
4Pancreatobiliary Cancer Center, Yonsei Cancer Center, Severance Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EUN JEONG CHOI
5Department of Food and Nutrition, Hanyang Women's University, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHANG MOO KANG
3Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea
4Pancreatobiliary Cancer Center, Yonsei Cancer Center, Severance Hospital, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nutrpine@yuhs.ac cmkang@yuhs.ac
SONG MI LEE
1Department of Nutrition Care, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nutrpine@yuhs.ac cmkang@yuhs.ac
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: High-carbohydrate diets are generally provided to post-pancreatectomy cancer patients. Low energy density of this diet may obstruct proper energy intake and recovery. This study aimed to assess the effects of high-fat, high-energy ketogenic diet (KD) in these patients. Patients and Methods: After pancreatectomy, 9 patients were provided with general diet (GD) while 10 were served KD. Meal compliance, energy intake rate, meal satisfaction and presence of complications were monitored throughout hospital stay. Data on nutritional status, serum lipids and body composition were collected and compared between groups. Results: Meal compliance, energy intake rate and meal satisfaction score were higher in KD. There were no differences in complications, nutritional status and serum lipids. The decrease in body cell mass (BCM) was greater in GD. Conclusion: Post-pancreatectomy cancer patients who consumed KD had a higher energy intake and BCM. These results suggest the potential use of KD as an adjuvant anti-cancer therapy.

  • Pancreatic cancer
  • pancreatectomy
  • ketogenic diet
  • adjuvant anti-cancer therapy

Pancreatic cancer accounts for 2.4% of the cancer incidence worldwide and has a particularly poor prognosis, resulting in 4.0% mortality. Gallbladder cancer accounts for 1.3% of all cancers with a mortality of 1.7% (1). Pancreatic cancer in South Korea was the eighth most common at 3% and gallbladder and other biliary cancers were the ninth most common at 2.9% in 2015 which, with regard to mortality, were ranked fifth with a rate of 7.2% and sixth with a rate of 5.6%, respectively. The five-year relative survival rate of pancreatic cancer was the lowest of all cancers at 10.8% (2).

Radical resection is the only method that can completely cure pancreatobiliary cancer, as complete tumor removal can considerably reduce the risk of cancer recurrence and increase patient survival rates (3, 4). However, patients who undergo pancreatectomy are more susceptible to malnourishment and weight loss due to complications such as pancreatic fistula, delayed gastric emptying, dumping syndrome, impaired digestive enzyme secretion, dysfunctional nutrient absorption, diarrhea, and steatorrhea (5). Furthermore, delayed or reduced food intake after surgery due to difficulty in consuming food can also induce weight loss. This weight loss may subsequently impact cancer cachexia caused by malignant tumors, malnutrition, and reduced quality of life (6, 7). Multiple studies have reported that cancer patients experience at least 10% of their total weight loss within six months after surgery due to cancer cachexia and that death caused by serious weight loss accounts for 80% of deaths caused by pancreatic cancer (8). According to a 2015 Korean study, 60% of patients who undergo pancreatoduodenectomy experience at least two factors that hinder food intake and subsequent weight loss, suggesting the need to improve the standard meals provided after pancreatectomy (9).

Recently, ketogenic diets (KD) have gained traction as a potential adjuvant anticancer therapy for targeting specific metabolic reactions of cancer tissues (10). Although its exact metabolic mechanisms are unknown, it has been speculated that ketosis caused by fasting inhibits cancer cell growth and that the restricted use of glucose during KD increases oxidative stress in cancer cells (11). Several clinical trials investigating the effects of KD in various cancer patients are currently being conducted. There have been relatively few studies on pancreatobiliary cancer patients, but these patients are customarily prescribed a high-carbohydrate, low-fat diet after pancreatectomy due to supposedly poor nutrient absorption, fat in particular. However, high-carbohydrate diets result in approximately 30% of required energy intake due to their low-calorie densities, making it difficult for patients to satisfy nutritional requirements after surgery. On the other hand, KD is high in fat and low in carbohydrates, which means that a patient can consume a sufficient amount of energy by consuming only a relatively small amount of food.

Therefore, this study aimed to investigate whether a high-fat, low-carbohydrate KD provided after radical pancreatectomy to treat pancreatobiliary cancer can improve dietary intake and patients' satisfaction compared to the general high-carbohydrate diet. Further, this study also investigated whether KD can improve patients' nutritional status and cancer-related clinical parameters such as serum lipids and lean body mass.

Materials and Methods

Ethics statement. This study was approved by the Institutional Review Board at Severance Hospital, Seoul, Korea (4-2016-079).

Study design. This prospective controlled intervention study was conducted from November 2016 to May 2017. Participants were adults who were diagnosed with a pancreatobiliary cancer, defined as either pancreatic cancer, duodenal cancer, distal biliary tract cancer, or carcinoma of the ampulla of vater, and were hospitalized to undergo pancreaticoduodenectomy or distal pancreatectomy. The patients who were excluded were pregnant women, severe diabetes patients with diabetic complications, hyperlipidemia patients with cardiovascular complications, patients with renal impairment below 90% of normal glomerular filtration rate, and illiterate patients. All participants understood the purpose of the study and voluntarily consented to participate in the study. Thirty patients were enrolled during the study period and sequentially assigned to either general diet (GD) group or KD group. After excluding 11 dropouts, a total of 19 patients were included in the data analysis (Figure 1).

Treatment. Anthropometric measurements, nutritional evaluation, and body composition analysis were performed before surgery (preOP), before discharge (DC), and at the first outpatient follow-up day (OPD) for all patients and general information (e.g., sex, age, diagnosis, type of surgery), blood and urine test results, and other relevant data were collected from electronic medical records (Figure 2).

After consuming a carbohydrate-supplement drink on the first day after surgery, the patients gradually began taking GD or KD in full liquid form and soft diet from postoperative day 3. The patients were instructed to record the percentage of each meal that they consumed in a daily log from the first day of the full liquid diet until the day of discharge. A research dietitian periodically visited patient to monitor the record keeping and check for problems with meal intake. Meal compliance was defined as the average percentage of provided meals consumed. At discharge, patients in KD group were given instructions on ketogenic diet and encouraged to consume KD at home. At OPD, the patients' 3-day food diaries (two weekdays and one weekend day) were examined during an interview. Dietary intakes were analyzed using the CAN-Pro 4.0 (Computer-Aided Nutritional Program) developed by Korean Nutrition Society to compute daily energy and protein intakes. Energy and protein intake rates were then calculated based on the energy and protein requirements of each patient. Energy requirement was calculated using the Mifflin-St. Jeor equation (12) with an estimated resting metabolic rate and a 25% activity factor. Protein requirement was set at 1 g/kg body weight.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Flow chart of study population. GD: General diet; KD: ketogenic diet.

Nutritional assessments were performed using the patient-generated subjective global assessment (PG-SGA), which is generally used for nutritional assessments of cancer patients (13). Body composition was analyzed using BIA (Biospace, Seoul, Korea) and generated body cell mass (BCM), body fat mass (BFM), and skeletal muscle mass (SMM) data. Serum cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride, C-reactive protein (CRP), and urine ketone were collected from electronic medical records during study period. Postoperative complications were investigated using the Clavien-Dindo classification. Patients with grade III or higher complications were defined as having developed complications for the purposes of this study (14).

General diet vs. ketogenic diet. Westman et al. (15) found that ketones are detected in the urine of people who consume 20-50 g of carbohydrates per day, so the subjects in KD group were provided with 3-6% of their daily energy as carbohydrates to induce ketosis. To promote postoperative recovery and prevent loss of body proteins, 1 g/kg of high-quality protein was provided. Further, 70-80% of energy was provided through fats to reach a ketogenic ratio of 1.05-1.75:1 (Fat: Carbohydrate+Protein, w:w). Fats were provided mainly in the form of vegetable oil, which was rich in unsaturated fat, and nuts, which had high levels of monounsaturated fats and phytosterols. Animal fats, found in products such as whipped cream and butter, were only used in small amounts. The general diet of this study was similar to usual Korean diet with carbohydrate:protein:fat (C:P:F) ratio of 55-65:7-20:15-30 (Table I).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Timing of survey during the study. CLD: Clear liquid diet; FLD: full liquid diet; SD: soft diet; PG-SGA: patient generated-subjective global assessment; POD: postoperative day; BCM: body cell mass; BFM: body fat mass; SMM: skeletal muscle mass.

Data analysis. Results are expressed as geometric means±standard deviation (SD). Data were verified for normality (Shapiro–Wilk test) and, when necessary, were log-transformed for normal distribution before further statistical analysis. Differences in general characteristics, meal compliance, energy and protein intake rates, meal satisfaction score, presence of meal intake-related problems, PG-SGA grade and urine ketone detection between GD and KD groups were compared by the Student's t test or Fisher's exact test. To determine whether there was a group x day interaction in meal compliance, dietary intake, serum lipid levels and body composition variables, 2-way ANOVA was performed. The changes of mean serum lipid levels and body composition variables over time in each group were analyzed by a repeated-measures 1-way ANOVA, followed by the Tukey–Kramer test for multiple comparisons. A Student's t test was performed to compare the difference in changes of serum lipid levels and body composition variables among groups (OPD – preOP). For this analysis, baseline-adjusted values were used. A p-value <0.05 was considered significant. Statistical analyses were performed using SAS version 9.4 (SAS Inc., Cary, NC, USA)

Results

Subject characteristics. Of the 10 participants assigned to the GD group, 1 was withdrawn from the study due to postoperative complications. Of the 20 participants assigned to the KD group, 10 were withdrawn from the study for stopping treatment (n=1), postoperative complications (n=2), insufficient data (n=1), and refusal to comply with the study meal (n=6). As a result, 9 participants in the GD group and 10 participants in the KD group completed the study. Table II shows a summary of their general information and anthropometric characteristics. There were no significant differences in the sex ratio, nutritional status, diagnosis, comorbidity, and type of surgery between the two groups. The GD group was older on average and had a lower average BMI than the KD group, but these differences were not statistically significant.

Meal compliance and rate of energy and protein intake. The first day during which participants began full liquid diets was designated as day 1. Daily meal compliance and energy and protein intake rates from day 1-10 were analyzed. The average meal compliance rate and energy intake rate in KD group were significantly higher than the GD group (Table III). Protein intake rate was also higher in KD group, but the difference was not statistically significant (p=0.0710).

Student's t-test was performed to compare the two groups at 10 points over the data collection period. The KD group had significantly higher meal compliance rates than the GD group during days 1-5 (p<0.05). Energy and protein intake rates were also higher in KD group at day 1 (p<0.01, Figure 3).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Composition of General and Ketogenic diets.

Dietary intake was also analyzed from DC to OPD based on the food records of the patients. Even though the KD group consumed slightly more fat and less carbohydrate, the dietary C:P:F ratio of the two groups did not differ. There were also no statistically significant differences in the energy and protein intake rates between the two groups (data now shown).

Meal satisfaction score and meal intake-related problems. On the third day of the soft diet, participants were surveyed about their meal satisfaction using a self-administered questionnaire (Table IV). There were no differences in satisfaction with the taste, saltiness, and smell of the meals between the two groups, but the KD group had higher volume, temperature, digestibility, and overall satisfaction scores than the GD group (p<0.05).

A research dietitian periodically visited patients to check for problems with dietary intake such as nausea, vomiting, constipation and diarrhea. There was no difference in proportion of patients suffering from meal intake-related problems. The total number of complaints were higher in GD group, but the difference was not statistically significant (Table V).

PG-SGA score. Figure 4 shows a comparison of the changes in patients' nutritional status during the study period. Nutritional states were classified into three grades according to the PG-SGA score: good (SGA A) or poor and requiring intervention (SGA B, SGA C). The proportion of patients in each grade was not different among groups at preOP. The percentage of SGA B and SGA C patients in both groups increased at DC, but there was no significant difference in these rates. Even though more patients in GD group were in either SGA B or SGA C grade at DC, but the difference from KD was not statistically significant.

Biochemical indices. Table VI shows the biochemical test results from throughout the study period. The KD group had a significantly lower cholesterol, HDL and LDL levels at DC than preOP (p<0.01). The GD group's HDL level decreased significantly, also (p<0.001). By OPD, these reduced levels returned to those comparable to preOP. The amount that this level was reduced (DC-preOP, OPD-preOP) was not significantly different between the two groups. The CRP level was significantly higher at DC in GD and KD groups (p<0.01 and p<0.001, respectively). At OPD, CRP level was not significantly different from preOP level in GD group. In KD, CRP level was still higher than that of preOP. However, the amount that this level was changed was not significantly different between groups, possibly due to large variation. There were no group x day interactions in levels of cholesterol, HDL, LDL, TG and CRP.

Body composition. Table VII shows the body composition analysis results from throughout the study period.

When compared to preOP levels, the body weight, BCM, and SMM of both groups were significantly lower at OPD (p<0.001). And the decreases in BCM were significantly greater in GD group (p<0.05). SMM decrease was also greater in GD group, though not significant (p=0.054). While BFM of the GD group was similar or slightly higher after surgery than before surgery, that of KD group was significantly lower at OPD than preOP (p<0.05). The degree of the changes in BFM was smaller in KD group, though the difference was not significant (p=0.086).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Baseline characteristics of subjects1.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Meal compliance, energy and protein intake rates among GD and KD groups during 10 days after the start of the meal1.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Daily meal compliance, energy and protein intake rates during the diet period. Values are presented as means±SDs. Significantly different between groups at each time point (Student's t-test): *p<0.05, **p<0.01, ***p<0.001. Energy Intake Rate: (actual energy intake)/(recommended energy intake) ×100; Protein Intake Rate: (actual protein intake)/(recommended protein intake) ×100.

Urine ketones. Table VIII shows the urine ketone detection before surgery, at discharge, and at outpatient visit. Before surgery, urine ketone bodies were detected in one patient in the KD group and none of the patients in the GD group. At DC, 70.0% of patients in the KD group had ketone bodies in their urine while only 22.2% of patients in the GD group did, but this difference was not statistically significant (p=0.069). There was no statistically significant difference between the two groups in the number of patients with urine ketone bodies at OPD.

Other than the three points mentioned above, numerous urine tests were performed on the patients during hospital stay. We pooled all the test results and calculated the ratio of times that each patient had urine ketone bodies. The ketone detection frequency was 22.2±23.7% in the GD group and 50.8±35.1% in the KD group, but the difference between the two groups was not statistically significant (p=0.065, data not shown).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Comparison of meal satisfaction scores between GD and KD groups1.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Frequency of meal intake-related problems1.

Complications after surgery. The incidence of postoperative complications was compared using the Clavien–Dindo classification (14). Whereas none of the patients in the KD group developed a postoperative complication, two patients (22.2%) in the GD group developed complications. However, this difference was not statistically significant (data not shown).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Change of PG-SGA grade among groups. 1PG-SGA: Patient-generated subjective global assessment; 2n (%); 3The differences among groups at each time point were tested by the Fisher's exact test. There was no significant difference between groups at p<0.05. Changes from preOP to DC in each group were tested by McNemar test. None of the changes was not statistically significant. preOP: Measurements of day before surgery; DC: measurements of day before discharge; OPD: measurements of first outpatient visits.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table VI.

Changes of biochemical indices during study period1.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table VII.

Changes of body composition during study period1.

Discussion

Schiesser et al. (16) reported that patients who underwent digestive system surgeries ate less per sitting and overall due to indigestion, early satiety while eating, abdominal fullness, and psychological fear of eating. Therefore, this study aimed to help pancreatobiliary cancer patients improve nutrient intake and recovery after surgery by providing a high-fat, high-calorie KD.

The KD used in this study was developed such that patients were able to obtain a large amount of energy from more frequent, smaller meals given the difficulty that such patients typically have with eating after surgery. In this study diet, patients were provided three meals and three snacks. Whereas the meals that the GD group received were ~750 g, the meals that the KD group received were ~210 g and snacks were ~160 g. A large portion of the KD was made up of nuts and oils, giving the KD 1.5 times more calories/g and 2 times more protein/g than the GD.

The findings of this study showed that postoperative patients who received the KD had greater meal compliance than patients who received the GD. In addition, patients in the KD group had higher energy intake rates, which is similar to the findings of Wallengren et al. (17) who found that increasing the nutritional density of meals received by cancer patients increased their energy intake rates. Amelioration of nutritional status through proper nutritional intake is important because it improves quality of life and survival in cancer patients undergoing chemotherapy following surgery (18-19). In this study, six patients assigned to KD refused to consume the diet. Of the six, three patients said they did not like KD because it is different from usual Korean diet which is low in fat and high in carbohydrate. The other three patients complained about the greasy smell from butter and cream of KD. The mean length of hospital stays for KD subjects who completed the study was 12±5.8 days while it was 19 days for those who withdrew, showing that the latter group stayed in the hospital statistically significantly longer (p<0.01, data not shown). In a single-arm pilot study, Schmidt et al. (20) found that participant motivation to eat meals influenced the induction of ketosis and the benefits received from meals. These results suggest that nutrition support team and medical professionals should actively intervene to motivate each patient to maximize the effects of the KD.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table VIII.

Comparison of urine ketone detection among GD and KD groups1.

The KD group showed significantly higher overall subjective satisfaction with their meals. The greatest difference in satisfaction between the two groups was with regard to the volume of food, because, as previously mentioned, the GD meals were almost 3.5 times larger than the KD meals. In addition, contrary to the aforementioned view of poor fat digestion, our results about meal intake-related problems showed that KD did not add extra burden to the digestive system in post-pancreatectomy patients. These results suggest that KD is a safe way to increase energy and nutrient intake in pancreatobiliary cancer patients after surgery.

The differences in meal compliance and nutrient intake rates between the KD group and GD group also induced differences in patients' nutritional status, biochemical parameters, and body compositions, though most of these differences were not statistically significant.

Nutritional status was assessed using PG-SGA grades. The proportion of patients in poor nutritional status (SGA B, SGA C) increased at DC in both groups, but the rate of increase was not statistically different. These results may have been due to the fact that both KD and GD groups were regularly assessed by a dietitian and were given nutritional interventions during the study.

This study's results showed that both groups had reduced serum lipid concentrations after surgery. This result was likely due to the reduction of blood cholesterol levels that occurs after physical traumas, as opposed to the food that the patients received. Numerous researchers reported that blood cholesterol concentration decreased substantially following major surgeries and that this reduced concentration persisted for approximately two weeks. The triglyceride concentration also decreases after surgery and returns to normal levels within several days (21-22). In this study, the lipid levels dropped in both groups and the level of decrease was not statistically different among groups. However, the reduction in LDL cholesterol levels tended to be greater in the KD group than in the GD group. These results were in line with the findings of Schmidt et al. (20) who found that providing protein and fat supplements in addition to carbohydrate-restricted diet to cancer patients led to a reduction in total cholesterol and LDL-cholesterol levels.

Recent studies have reported that low-carbohydrate, high-fat diets have benefits for weight loss and cardiovascular diseases by having a positive impact on lipid metabolism. Sharman et al. found that those who ate a diet consisting of 30% protein, 8% carbohydrates, and 61% fat had lower serum triglyceride concentration, high HDL-cholesterol concentration, and smaller LDL-cholesterol particles than those who ate a regular diet, which ultimately reduced cardiovascular risk (23). However, these studies were conducted on healthy adults, so additional studies are needed to investigate the effects of these types of diets on lipid metabolism in cancer patients. In this study, nuts and vegetable oils were used as major sources of fat. These foods are rich in polyunsaturated fatty acid and phytosterols which are known to improve lipid profile (24, 25). Therefore, the reduction of total cholesterol and LDL-cholesterol after eating the KD was likely due to the rich unsaturated fatty acid and phytosterol content of the diet.

Regarding body composition changes during the study period, the GD group maintained or mildly increased BFM after surgery but the KD group had significantly reduced BFM one month after surgery. Similar findings were reported in the study by Klement and Sweeney (26) in which a KD was provided to patients undergoing adjuvant radiotherapy. This study's findings were also in line with a study that found that a KD is effective in treating obesity (27). In this study, BCM and SMM decreased over time, but the degree of these changes was greater in the GD group than in the KD group (p<0.05). The difference between GD and KD group was not significant after adjustment with age, but this finding suggests that ketogenic diet is beneficial in preserving lean body mass. A recent study reported that reduction of lean body mass and body weight is a sign of malnutrition (28). Therefore, this study showed that KD developed in this study is effective in preserving lean body mass and nutritional status of cancer patients after pancreatectomy.

In this study, urine ketones were detected more frequently in the KD, though the difference was not statistically significant. The KD group also had a significantly higher serum ketone body concentration (β-hydroxybutyrate) than the GD group (unpublished data). So, it is clear that KD in this study has elevated ketone bodies concentration in the system. However, it should be addressed that there are a few differences between this study and previous studies administering a KD. First, the ketogenic ratio in this study was 1.05-1.75:1, which was different from the 4:1-3:1 ratio commonly reported in the literature. Furthermore, a previous study argued that a KD should be provided for at least three weeks in order to induce ketosis (11), but this study found an increase in urine ketone bodies within an average of two weeks or less. Moreover, ketone body analysis was qualitative, not quantitative in this study. Therefore, further studies are needed to clarify the dose and duration of this KD to induce ketosis. Also, more studies are necessary to elucidate the effect of KD in cancer metabolism of pancreatobiliary patients.

In summary, the KD designed in this study improved meal compliance, satisfaction, and energy intake rate in post-pancreatectomy patients without increasing complications of the digestive system. Furthermore, it induced changes in the metabolic state, indicating that it can improve clinical parameters as well. In addition, urine ketone bodies tended to increase after consuming KD. Therefore, this study showed that KD is a safe adjuvant nutritional intervention in pancreatobiliary cancer treatment and provided foundational data for subsequent studies investigating the anti-cancer effects of KDs.

However, one limitation was that strict randomization was not possible because the participants were patients who needed immediate cancer surgeries. Additional randomized controlled trials conducted with a larger number of participants are needed to assess the effects of KD as an adjuvant anti-cancer therapy.

Acknowledgements

This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (iPET, 316055-3).

Footnotes

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors of this article have no conflicts of interest to declare.

  • Received September 18, 2018.
  • Revision received September 28, 2018.
  • Accepted October 1, 2018.
  • Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Ferlay J,
    2. Soerjomataram I,
    3. Dikshit R,
    4. Eser S,
    5. Mathers C,
    6. Rebelo M,
    7. Parkin DM,
    8. Forman D,
    9. Bray F
    : Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5): E359-386, 2015.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Center NCI
    . Cancer Statistics. http://www.cancer.go.kr/lay1/S1T639C641/contents.do.
  3. ↵
    1. Hartwig W,
    2. Hackert T,
    3. Hinz U,
    4. Gluth A,
    5. Bergmann F,
    6. Strobel O,
    7. Buchler MW,
    8. Werner J
    : Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254(2): 311-319, 2011.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Berry AJ
    : Pancreatic surgery: indications, complications, and implications for nutrition intervention. Nutr Clin Pract 28(3): 330-357, 2013.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Gilliland TM,
    2. Villafane-Ferriol N,
    3. Shah KP,
    4. Shah RM,
    5. Tran Cao HS,
    6. Massarweh NN,
    7. Silberfein EJ,
    8. Choi EA,
    9. Hsu C,
    10. McElhany AL,
    11. Barakat O,
    12. Fisher W,
    13. Van Buren G
    : Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection. Nutrients 9(3): pii: E243, 2017.
  6. ↵
    1. Park JW,
    2. Jang JY,
    3. Kim EJ,
    4. Kang MJ,
    5. Kwon W,
    6. Chang YR,
    7. Han IW,
    8. Kim SW
    : Effects of pancreatectomy on nutritional state, pancreatic function and quality of life. Br J Surg 100(8): 1064-1070, 2013.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Pappas S,
    2. Krzywda E,
    3. McDowell N
    : Nutrition and pancreaticoduodenectomy. Nutr Clin Pract 25(3): 234-243, 2010.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Bozzetti F,
    2. Mariani L,
    3. Lo Vullo S,
    4. Group SW,
    5. Amerio ML,
    6. Biffi R,
    7. Caccialanza G,
    8. Capuano G,
    9. Correja I,
    10. Cozzaglio L,
    11. Di Leo A,
    12. Di Cosmo L,
    13. Finocchiaro C,
    14. Gavazzi C,
    15. Giannoni A,
    16. Magnanini P,
    17. Mantovani G,
    18. Pellegrini M,
    19. Rovera L,
    20. Sandri G,
    21. Tinivella M,
    22. Vigevani E
    : The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer 20(8): 1919-1928, 2012.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Kang J,
    2. Park JS,
    3. Yoon DS,
    4. Kim WJ,
    5. Chung HY,
    6. Lee SM,
    7. Chang N
    : A study on the dietary intake and the nutritional status among the pancreatic cancer surgical patients. Clin Nutr Res 5(4): 279-289, 2016.
    OpenUrl
  10. ↵
    1. Allen BG,
    2. Bhatia SK,
    3. Anderson CM,
    4. Eichenberger-Gilmore JM,
    5. Sibenaller ZA,
    6. Mapuskar KA,
    7. Schoenfeld JD,
    8. Buatti JM,
    9. Spitz DR,
    10. Fath MA
    : Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol 2: 963-970, 2014.
    OpenUrl
  11. ↵
    1. Oliveira CLP,
    2. Mattingly S,
    3. Schirrmacher R,
    4. Sawyer MB,
    5. Fine EJ,
    6. Prado CM
    : A Nutritional perspective of ketogenic diet in cancer: a narrative review. J Acad Nutr Diet 118(4): 668-688, 2018.
    OpenUrl
  12. ↵
    1. Weijs PJ,
    2. Kruizenga HM,
    3. van Dijk AE,
    4. van der Meij BS,
    5. Langius JA,
    6. Knol DL,
    7. Strack van Schijndel RJ,
    8. van Bokhorst-de van der Schueren MA
    : Validation of predictive equations for resting energy expenditure in adult outpatients and inpatients. Clin Nutr 27(1): 150-157, 2008.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Bauer J,
    2. Capra S,
    3. Ferguson M
    : Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56(8): 779, 2002.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Dindo D,
    2. Demartines N,
    3. Clavien P-A
    : Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2): 205, 2004.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Westman EC,
    2. Feinman RD,
    3. Mavropoulos JC,
    4. Vernon MC,
    5. Volek JS,
    6. Wortman JA,
    7. Yancy WS,
    8. Phinney SD
    : Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 86(2): 276-284, 2007.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Schiesser M,
    2. Müller S,
    3. Kirchhoff P,
    4. Breitenstein S,
    5. Schäfer M,
    6. Clavien PA
    : Assessment of a novel screening score for nutritional risk in predicting complications in gastro-intestinal surgery. Clin Nutrit 27(4): 565-570, 2008.
    OpenUrl
  17. ↵
    1. Wallengren O,
    2. Lundholm K,
    3. Bosaeus I
    : Diet energy density and energy intake in palliative care cancer patients. Clin Nutr 24(2): 266-273, 2005.
    OpenUrlPubMed
  18. ↵
    1. De Waele E,
    2. Mattens S,
    3. Honore PM,
    4. Spapen H,
    5. De Greve J,
    6. Pen JJ
    : Nutrition therapy in cachectic cancer patients. The Tight Caloric Control (TiCaCo) pilot trial. Appetite 91: 298-301, 2015.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Langius JA,
    2. Zandbergen MC,
    3. Eerenstein SE,
    4. van Tulder MW,
    5. Leemans CR,
    6. Kramer MH,
    7. Weijs PJ
    : Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo) radiotherapy: a systematic review. Clin Nutr 32(5): 671-678, 2013.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Schmidt M,
    2. Pfetzer N,
    3. Schwab M,
    4. Strauss I,
    5. Kämmerer U
    : Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metabol 8(1): 1-13, 2011.
    OpenUrl
  21. ↵
    1. Kesteloot H,
    2. Cobbaert C,
    3. Meyns B,
    4. Szecsi J,
    5. Lesaffre E,
    6. Sergeant P
    : Time course of serum lipid and lipoprotein levels after coronary bypass surgery: modification by pravastatin. Acta Cardiol 47(6): 519-528, 1992.
    OpenUrlPubMed
  22. ↵
    1. Malmendier CL,
    2. Amerijckx JP,
    3. Bihain BE,
    4. Fischer ML
    : Changes in apolipoprotein and lipids in patients after surgery. Biomed Pharmacother 39(4): 192-195, 1985.
    OpenUrlPubMed
  23. ↵
    1. Sharman MJ,
    2. Kraemer WJ,
    3. Love DM,
    4. Avery NG,
    5. Gómez AL,
    6. Scheett TP,
    7. Volek JS
    : A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 132(7): 1879-1885, 2002.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Kris-Etherton PM,
    2. Pearson TA,
    3. Wan Y,
    4. Hargrove RL,
    5. Moriarty K,
    6. Fishell V,
    7. Etherton TD
    : High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 70(6): 1009-1015, 1999.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Jones PJ,
    2. MacDougall DE,
    3. Ntanios F,
    4. Vanstone CA
    : Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol 75(3): 217-227, 1997.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Klement RJ,
    2. Sweeney RA
    : Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients. BMC Res Notes 9(1): 143, 2016.
    OpenUrl
  27. ↵
    1. Paoli A
    : Ketogenic diet for obesity: friend or foe? Int J Environ Res Public Health 11(2): 2092-2107, 2014.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Jensen GL,
    2. Mirtallo J,
    3. Compher C,
    4. Dhaliwal R,
    5. Forbes A,
    6. Grijalba RF,
    7. Hardy G,
    8. Kondrup J,
    9. Labadarios D,
    10. Nyulasi I
    : Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. J Parenter Enteral Nutr 34(2): 156-159, 2010.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (11)
Anticancer Research
Vol. 38, Issue 11
November 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy
JU HYE OK, HOSUN LEE, HAE-YUN CHUNG, SUNG HWAN LEE, EUN JEONG CHOI, CHANG MOO KANG, SONG MI LEE
Anticancer Research Nov 2018, 38 (11) 6519-6527; DOI: 10.21873/anticanres.13017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy
JU HYE OK, HOSUN LEE, HAE-YUN CHUNG, SUNG HWAN LEE, EUN JEONG CHOI, CHANG MOO KANG, SONG MI LEE
Anticancer Research Nov 2018, 38 (11) 6519-6527; DOI: 10.21873/anticanres.13017
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Cytotoxicity of Exogenous Acetoacetate in Lithium Salt Form Is Mediated by Lithium and Not Acetoacetate
  • Google Scholar

More in this TOC Section

  • Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan
  • Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
  • Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National Cancer Database
Show more Clinical Studies

Similar Articles

Keywords

  • Pancreatic cancer
  • pancreatectomy
  • Ketogenic diet
  • adjuvant anti-cancer therapy
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire